Search Publications

Publications

Pubmed ID Author Year Title

2024923

Bojanic S

1991

Serum progesterone concentration is raised during early follicular phase in women with polycystic ovaries.

2031901

Fox R

1991

Acromegaloid bone changes in severe polycystic ovarian disease: an effect of hyperinsulinaemia? Case report.

2035966

Barbieri RL

1991

Polycystic ovarian disease.

2037103

Ardaens Y

1991

Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis.

2037115

Dabirashrafi H

1991

Adhesion formation after ovarian electrocauterization on patients with polycystic ovarian syndrome.

2042357

Manusharova RA

1991

[The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease].

2042426

Klug PW

1991

[Role of vaginal sonography in the assessment of adnexa tumors].

2042697

Stack PS

1991

Ovarian hyperstimulation syndrome.

2042717

Demidov VN

1991

[Possibilities of echography in the diagnosis of polycystic ovary syndrome].

2045705

Yoshino K

1991

Peripheral catecholamine metabolites and free testosterone in patients with polycystic ovary syndrome.

2048615

Davajan V

1991

Ten-year follow-up of patients with secondary amenorrhea and normal prolactin.

2058208

Carol W

1991

[Hirsutism and androgenic menstrual cycle irregularities].

2058330

von Holst T

1991

[Endocrinology of the peri- and postmenopausal period].

2058338

Kadylak B

1991

Degeneratio cystica ovarii neonatorum.

2058952

Urdl W

1991

Interactions between insulin and insulin-like growth factor I in the pathogenesis of polycystic ovarian disease.

2058954

Franks S

1991

Obesity and polycystic ovary syndrome.

2058955

Lunenfeld B

1991

Modern aspects of ovulation induction.

2066688

Franks S

1991

The ubiquitous polycystic ovary.

2067516

Young RH

1991

Ovarian pathology of infertility.

2067758

Falcone T

1991

Serum inhibin levels in polycystic ovary syndrome: effect of insulin resistance and insulin secretion.

2079317

Mahabeer S

1990

Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease.

2080142

Dedov II

1990

[The effect of acute ACTH1-24 loading on the steroid hormone and prolactin content of the blood serum in women with hyperprolactinemia and hyperandrogenism].

2087465

Goncharov NP

1990

[The development of a variant immunoenzyme method for determining testosterone and its use for assessing gonadal androgenic activity].

2090004

Prilepskaia VN

1990

[Secondary amenorrhea].

2095356

Kinoshita T

1990

Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS).

2095357

Taketani Y

1990

A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.

2095358

Taketani Y

1990

Pathophysiology of polycystic ovary syndrome. Overview.

2095359

Nakamura Y

1990

Treatment of polycystic ovary syndrome: an overview.

2097874

Weise W

1990

Transvaginal operation of the Stein-Leventhal syndrome: description of a new operative technique.

2102331

Fox R

1990

Polycystic ovarian disease.

2105793

Johnson P

1990

Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation.

2106449

Larsen T

1990

Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.

2106527

Dunaif A

1990

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome.

2107120

Etzrodt A

1990

[FSH-producing hypophyseal tumor in a 13-year-old girl].

2107649

Graf M

1990

[Clinical and endocrinologic aspects of treatment with pure FSH. A report of experiences].

2108185

Erickson GF

1990

The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.

2108981

Homburg R

1990

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.

2108986

Lanzone A

1990

Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.

2109647

McCarthy GF

1990

Plasma gonadotropin patterns characterizing the development of polycystic ovaries in the estradiol valerate treated rat.

2109679

Brogden RN

1990

Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

2110046

Fleming R

1990

Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH.

2110070

McFaul PB

1990

Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.

2110071

Tanbo T

1990

Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.

2110544

Lanzone A

1990

Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.

2110712

Prelevi? GM

1990

LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.

2111696

Yoshino K

1990

Plasma catecholamine metabolites and polycystic ovary syndrome.

2112067

Kiddy DS

1990

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.

2113488

Bachus KE

1990

The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate.

2113505

Bider D

1990

Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.

2113560

Nagai K

1990

[Hyperthecosis and endocrinological study].

2113856

Mici? D

1990

Naloxone interaction with pituitary response to TRH and LHRH test in patients with polycystic ovary syndrome.

2114434

Venturini PL

1990

Luteinizing hormone determinations obtained with either a monoclonal and a polyclonal antibody radioimmunoassay and their correlations with clinical findings.

2115566

Macleod AF

1990

Effect of long-term inhibition of gonadotrophin secretion by the gonadotrophin-releasing hormone agonist, buserelin, on sex steroid secretion and ovarian morphology in polycystic ovary syndrome.

2116328

Kelly AC

1990

Alternate regimens for ovulation induction in polycystic ovarian disease.

2116945

Gadir AA

1990

Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization.

2120089

Homburg R

1990

Treatment with pulsatile luteinizing hormone-releasing hormone modulates folliculogenesis in response to ovarian stimulation with exogenous gonadotropins in patients with polycystic ovaries.

2120380

Mason HD

1990

Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro.

2121397

Mason HD

1990

Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries.

2122727

Jaffe RB

1990

Pulsatile GnRH in clinical medicine. Introductory remarks.

2122730

Filicori M

1990

Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.

2122768

McCarthy GF

1990

Induction of Stein-Leventhal-like polycystic ovaries (PCO) in the rat: a new model for cystic ovarian disease.

2123759

Abdel Gadir A

1990

Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease.

2124095

Szil?gyi A

1990

Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.

2126241

Sir-Petermann T

1990

Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.

2128692

Mahabeer S

1990

125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.

2128878

Tanabe K

1990

The role of inhibin in women with polycystic ovary syndrome (PCOS).

2128879

Ito T

1990

A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).

2128880

Tasaka K

1990

Electrocautery in polycystic ovary syndrome.

2128881

Nakamura Y

1990

Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.

2128882

Tanaka T

1990

Endocrinological environment of polycystic ovarian disease.

2132194

Mahabeer S

1990

Insulin levels and 125I-insulin binding to monocytes in a non obese pregnant woman with polycystic ovarian disease.

2132474

Cignitti M

1990

Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.

2134217

Mahabeer S

1990

Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.

2136836

Armar NA

1990

Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome.

2137133

Azziz R

1990

On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.

2137846

Vexiau P

1990

Androgen excess in women with acne alone compared with women with acne and/or hirsutism.

2138570

Sakata M

1990

Changes of bioactive luteinizing hormone after laparoscopic ovarian cautery in patients with polycystic ovarian syndrome.

2138630

Farah MJ

1990

Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans.

2138647

Sonino N

1990

Low-dose ketoconazole treatment in hirsute women.

2139916

Cedeno J

1990

Effect of ketoconazole on plasma sex hormones, lipids, lipoproteins, and apolipoproteins in hyperandrogenic women.

2140734

Obhrai M

1990

Hormonal studies on women with polycystic ovaries diagnosed by ultrasound.

2142562

Keckstein G

1990

[Pelviscopic use of the CO2 laser in the treatment of polycystic ovary syndrome].

2142827

Keckstein G

1990

The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser.

2143054

Ataniiazova OA

1990

[Polycystic ovary syndrome with excess of prolactin].

2143826

Bringer J

1990

[Pulsatile administration of gonadotropin releasing hormone in the female. Diagnostic and therapeutic indications].

2145442

Qiao FY

1990

[Significance of sex hormone binding globulin and free androgen index in the estimation of androgenic cases].

2146285

Falcone T

1990

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.

2146898

Alieva EA

1990

[Results of laparoscopy in patients with polycystic ovary syndrome after surgical treatment].

2147009

Betti R

1990

Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports.

2147602

Golland IM

1990

Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.

2148677

Gj?nnaess H

1990

A simple treatment for polycystic ovarian syndrome.

2149487

Hamori M

1990

Ovarian response patterns to human menopausal gonadotropin in mixed hyperandrogenemia.

2149912

Sobbrio GA

1990

Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.

2150631

Falsetti L

1990

Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.

2151090

Alieva EA

1990

[The polycystic ovary syndrome and increased body mass].

2151091

Gasparov AS

1990

[Androgenization in patients with polycystic ovary syndrome].

2151092

Gasparov AS

1990

[Endoscopic surgery in the treatment of polycystic ovary syndrome].

2151330

Utsunomiya T

1990

Hormonal and clinical effects of multifollicular puncture and resection on the ovaries of polycystic ovary syndrome.

2152100

Alijevov? EA

1990

[Laparoscopy after wedge resection of the ovary in patients with polycystic ovary syndrome].

2153591

Dale PO

1990

Pregnancy after transfer of cryopreserved embryos in clomiphene citrate resistant polycystic ovarian syndrome.